These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15497779)

  • 1. [Immunophenotyping of haematologic malignancies].
    Koehorst SG; Evers H; van Buul T; de Vries F; Haanen C
    Ned Tijdschr Geneeskd; 2004 Sep; 148(38):1861-5. PubMed ID: 15497779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunophenotyping of leukemia: overview].
    Huber K; Worofka B; Kittl E; Tomasits J; Hofmann J; Bauer K
    Wien Klin Wochenschr; 1994; 106(8):226-30. PubMed ID: 8023514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical uses of flow cytometry in hematological oncology].
    D'Ostilio A; Ginaldi L; Marini L; Di Gennaro A; De Martinis M; Quaglino D
    Recenti Prog Med; 1997 Apr; 88(4):157-65. PubMed ID: 9206811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry and its use in the diagnosis and management of mature lymphoid malignancies.
    de Tute RM
    Histopathology; 2011 Jan; 58(1):90-105. PubMed ID: 21261686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry. Clinical and research applications in hematologic malignancies.
    Huh YO; Andreeff M
    Hematol Oncol Clin North Am; 1994 Aug; 8(4):703-23. PubMed ID: 7961287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative identification of blood cell markers in human hematopoietic malignancies with diagnostic and prognostic significance.
    Kusenda J
    Neoplasma; 2008; 55(5):381-6. PubMed ID: 18665747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Flow cytometry--use in cell biology and benefits in clinical medicine].
    Clausen OP; Olsen G; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2000 Feb; 120(4):489-95. PubMed ID: 10833942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A relational database for diagnosis of hematopoietic neoplasms using immunophenotyping by flow cytometry.
    Nguyen AN; Milam JD; Johnson KA; Banez EI
    Am J Clin Pathol; 2000 Jan; 113(1):95-106. PubMed ID: 10631862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphology and immunophenotyping in hematological malignancies].
    Kawai Y; Shimizu N; Ujiie M; Takeshita E; Todoroki T; Mitsuhashi T; Watanabe K
    Rinsho Byori; 2000 Aug; 48(8):694-701. PubMed ID: 11064591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
    Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia.
    Wood BL; Arroz M; Barnett D; DiGiuseppe J; Greig B; Kussick SJ; Oldaker T; Shenkin M; Stone E; Wallace P
    Cytometry B Clin Cytom; 2007; 72 Suppl 1():S14-22. PubMed ID: 17803189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of malignant haematopoietic cells in the cerebrospinal fluid by conventional cytology and flow cytometry.
    Nückel H; Novotny JR; Noppeney R; Savidou I; Dührsen U
    Clin Lab Haematol; 2006 Feb; 28(1):22-9. PubMed ID: 16430456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OMIP-010: a new 10-color monoclonal antibody panel for polychromatic immunophenotyping of small hematopoietic cell samples.
    Preijers FW; Huys E; Moshaver B
    Cytometry A; 2012 Jun; 81(6):453-5. PubMed ID: 22532446
    [No Abstract]   [Full Text] [Related]  

  • 14. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
    Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
    Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometry immunophenotyping of hematolymphoid neoplasia.
    Calvo KR; McCoy CS; Stetler-Stevenson M
    Methods Mol Biol; 2011; 699():295-316. PubMed ID: 21116989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
    Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometry applications in detection and classification of leukemia/lymphoma.
    Widen RH
    J Fla Med Assoc; 1992 Dec; 79(12):841-4. PubMed ID: 1474369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Flow cytometry: application for the diagnosis and the follow-up of hematological malignancies].
    Drénou B; Fardel O; Fauchet R; Amiot L
    Ann Biol Clin (Paris); 2002; 60(6):663-72. PubMed ID: 12446230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of a germinal center immunophenotype in lymphomas by immunocytochemistry and flow cytometry.
    Jack A; Barrans S; Blythe D; Rawstron A
    Methods Mol Med; 2005; 115():65-91. PubMed ID: 15998963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative immune phenotyping: a new dimension for the monitoring of haemopoietic malignancies.
    Lavabre-Bertrand T; George F; Brunet C; Sampol J
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):373-82. PubMed ID: 7892132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.